MedPath

Perioperative Neuroprotection of Stellate Ganglion Block

Not Applicable
Conditions
Intracranial Aneurysm
Interventions
Drug: Stellate Ganglion Block
Registration Number
NCT02275247
Lead Sponsor
General Hospital of Ningxia Medical University
Brief Summary

To investigate whether stellate ganglion block is helpful to brain protection during cranial aneurysm surgery

Detailed Description

The vasospasm after cranial aneurysm surgery have a higher incidence, but not have an ideal treatment method. At present, the medical treatment is very limited effect to prevent the perioperative cerebral ischemia.Stellate ganglion block (SGB)is an effective and well-tolerated approach to the treatment of CVS in various clinical settings.Resent study indicated that SGB has a protective effect on delayed cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage.Therefore,we hypothesized that the preoperative SGB would be a effective treatment for improvement of vasospasm after cranial aneurysm surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • aneurysm subarachnoid hemorrhage patients scheduled for cranial aneurysm surgery,
  • ASA grade:Ⅱ-Ⅲ,
  • Hunt~Hess grade :Ⅰ-Ⅲ,
  • have a informed consent.
Exclusion Criteria
  • history of mental illness,
  • local infection who can't do stellate ganglion block,
  • pregnant or lactating,
  • nausea cancer or diabetes,
  • participated the study or other related research in the last 30 days,
  • unruptured aneurysms patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention 'Stellate Ganglion Block'Stellate Ganglion BlockExperimental patients will receive a stellate ganglion block with 0.25% ropivacaine 6-8mL on the right side at the level of the sixth cervical vertebrae (C6) before surgery.Then the catheter will be attached to a single use patient-controlled analgesia pump containing 0.2% ropivacaine 150 mL, which will be infused at 2 mL/h.
Primary Outcome Measures
NameTimeMethod
The incidence of cerebral vasospasmChange from baseline at 2hour,6hour,1day,3day,and 7day after aneurysm surgery

The occurrence of cerebral vasospasm will be diagnosed by using of the transcranial doppler instrument.

Secondary Outcome Measures
NameTimeMethod
Perioperative cerebral oxygen metabolismChange from baseline at 2hour,6hour,1day,3day,and 7day postoperatively

Cerebral oxygen metabolism will be monitored through jugular venous oxygen saturation (SjVO2) and cerebral extraction rate of oxygen (CERO2), and measured by blood gas analysis at each time point, the latter will be calculated using the formula:

CaO2 = (Hb\*1.38\*SaO2) + (0.003\*PaO2); CvO2 = (Hb\*1.38\*SjvO2) + (0.003\*PjvO2); CERO2 = (CaO2-CvO2)/CaO2 where CaO2 is arterial oxygen content, Hb is arterial hemoglobin concentration, SaO2 is arterial oxygen saturation, PaO2 is the arterial partial pressure of oxygen, CvO2 is mixed venous oxygen content and PjvO2 is the jugular venous partial pressure of oxygen.

The difference of plasma endothelin, melatonin, and S100-β protein level between two groups at each time pointChange from baseline at 2hour,6hour,1day,3day,and 7day postoperatively

A 5-mL jugular venous blood sample will be taken at each time point, centrifuged at 3,000 rpm for 25 min, and kept in a freezer at -80°C until analysis. the concentrations of plasma endothelin, melatonin, and S100-β protein will be measured using enzyme-linked immunosorbent assays.

Postoperative cognitive functionChange from baseline at 2hour,6hour,1day,3day,and 7day after aneurysm surgery

The postoperative cognitive function will be measured by using of the mini-mental state examination (MMSE).

Trial Locations

Locations (1)

General Hospital of Ningxia Medical University

🇨🇳

Yinchuan, Ningxia, China

© Copyright 2025. All Rights Reserved by MedPath